When the clinical and in vivo studies of Echinacea are carefully examined, most conclude that the herb increases phagocytic activity. Even the polysaccharides only enhance macrophage activity and killing (Bauer and Wagner, 1991). Phagocytic cells are part of nonspecific immunity. What is often not appreciated is that the activities of phagocytic cells, especially macrophages, are a key element of immune surveillance. The macrophage secretes several immune-enhancing cytokines and pro cesses antigenic material and then presents this to the helper T-cell. Helper T-cells can only effectively respond to antigen presented in this way. Hence, if an herb such as Echinacea significantly increases phagocytic activity, the end result will be enhanced immune surveillance. For infections in general, the fact that Echinacea increases phagocytic activity emphasizes that it works best as a prophylactic or in the very early stages of an infection. This is because enhanced phagocytosis gives better direct clearance and inactivation of pathogenic organisms by phagocytes, which is one of the first lines of immune defense, and better immune surveillance, which accelerates the response of the immune system to the new pathogen or to other opportunistic pathogens.
That Echinacea works best as a preventative is consistent with the clinical experience of many phytotherapists, although this activity has not been borne out by recent studies (Melchart and Linde, 1999). In fact, it may be more accurate to describe Echinacea as an immunomodulator. While it stimulates phagocytic activity, this may have the end result of modulating immune function overall. For example, the chronic presence of a microorganism may cause a state of immune dysregulation that results in autoimmune disease or a chronic inflammatory condition such as asthma. Such theories have been proposed in the mainstream scientific literature (Bone, 1999). A substance that enhances immune surveillance may help the body to eliminate the organism or neutralize its imbalancing effect on the immune system, thereby toning down an inappropriate immune response. Similarly, the body's response to an allergen may be reduced if a more appropriate response results from enhanced phagocytic activity and immune recognition.
Limitations on the oral use of Echinacea have resulted from preconceived and simplistic concepts of the immune system and Echinacea's influence on it. Misinterpretations or overinterpretations in the scientific literature have confounded the problem. Confounding this issue further are the observations that the term Echinacea is used to describe many different preparations and the phytochemical content of Echinacea products varies considerably. However, the weight of evidence, including traditional, observational, and scientific, is that limitations on the use of Echinacea are ill advised.
Perhaps if the understanding of Echinacea's activity after oral doses were shifted toward the concept of an immunomodulator rather than an immunostimulant, concerns about its use would abate. Echinacea is undoubtedly one of the most valuable herbs in use in the world today. Misconceptions about its use can only devalue its role in modern health care and needlessly restrict the efficacy of herbal therapy.
Bauer, R., Jurcic, K., Puhlmann, J. and Wagner, H., 1988, Immunological in vivo and in vitro examinations of Echinacea extracts, Arzneim. Forsch., 38: 276-281. Bauer, R., Remiger, P., Jurcic, K., et al., 1989, Influence of Echinacea extracts on phagocytotic activity, Z. Phytother., 10: 43-48.
Bauer, R. and Wagner, H., 1991, Echinacea species as potential immunostimulatory drugs, in Wagner H. and Farnsworth, N.R., Eds., Economic and Medicinal Plant Research, vol. 5, Academic Press, New York, pp. 253-321.
Bauer, R. and Wagner, H., 1996, Stellungnahme: Keine panik wegen Echinacea, Z. Phytother., 17: 251-252. Bisset, N.G., Ed., 1994, Herbal Drugs and Phytopharmaceuticals, CRC Press, Boca Raton, FL, pp. 182-184. Blumenthal, M., et al., Eds., 1998, The Complete German Commission E Monographs: Therapeutic Guide to
Herbal Medicines, American Botanical Council, Austin, TX. Bone, K.M., 1995a, Treating autoimmune disease — part 1, Modern Phytother., 1: 1-8. Bone, K.M., 1995b, Treating autoimmune disease — part 2, Modern Phytother., 1: 15-27.
Bone, K.M., 1999, Phytotherapy review and commentary. Autoimmune disease: a phytotherapeutic perspective, Townsend Lett. Doctors Patients, 193/194: 94-98.
Burger, R.A., Torres, A.R., Warren, R.P., et al., 1997, Echinacea-induced cytokine production by human macrophages, Int. J. Immunopharmacol., 19: 371-379.
Coeugniet, E.G. and Kühnast, R., 1986, Adjuvante immuntherapie mit verschiedenen Echinacin®-Darrei-chungsformen, Therapiewoche, 36: 3352-3358.
Dennehy, C., 2001, Need for additional, specific information in studies with Echinacea, Antimicrob. Agents Chemother., 45: 369-370.
Dietz, B., Heilmann, J. and Bauer, R., 2001, Absorption of dodeca-2E,4E,8Z,10E/Z-tetraenoic acid isobuty-lamides after oral application of Echinacea purpurea tincture, Planta Med., 67: 863-864.
Ellingwood, F., 1993, American Materia Medica, Therapeutics and Pharmacognosy, vol. 2, Eclectic Medical Publications, Portland, OR.
Felter, H.W. and Lloyd, J.U., 1993, King's American Dispensatory, 18th ed., vol. 1, Eclectic Medical Publications, Portland, OR.
Goel, V., Chang, C., Slama, J., et al., 2002, Alkylamides of Echinacea purpurea stimulate alveolar macrophage function in normal rats, Int. Immunopharmacol., 2: 381-387.
Hansen, F., 1996, Echinacea unter verdacht, Die Zeit, 10 May, supplement 20.
Jurcic, K., Melchart, D., Holzmann, M., et al., 1989, Zwei probandenstudien zur stimulierung der granulozyten-phagozytose durch Echinacea-extrakt-haltige präparate, Z. Phytother., 10: 67-70.
Kim, H.O., Durance, T.D., Scaman, C.H., et al., 2000a, Retention of caffeic acid derivatives in dried Echinacea purpurea, J. Agric. Food Chem., 48: 4182-4186.
Kim, H.O., Durance, T.D., Scaman C.H., et al., 2000b, Retention of alkamides in dried Echinacea purpurea, J. Agric. Food Chem., 48, 4187-4192.
Lehmann, R., 2002, Personal communication, September.
Lohmann-Matthes, M.-L. and Wagner, H., 1989, Macrophage activation by plant polysaccharides, Z. Phytother., 10: 52-59.
Melchart, D. and Linde, K., 1999, Clinical investigations of Echinacea phytopharmaceuticals, in Wagner, H., Ed., Immunomodulatory Agents from Plants, Birkhauser Verlag, Basel.
Melchart, D., Clemm, C., Weber, B., et al., 2002, Polysaccharides isolated from Echinacea purpurea herba cell cultures to counteract undesired effects of chemotherapy — a pilot study, Phytother. Res., 16: 138-142.
Mullins, R.J., 1998, Echinacea-associated anaphylaxis, Med. J. Aust., 168: 170-171.
Mullins, R.J. and Heddle, R., 2002, Adverse reactions associated with Echinacea: the Australian experience, Ann. Allergy Asthma Immunol., 88: 42-51.
Nusslein, B., Kurzmann, M., Bauer, R., et al., 2000, Enzymatic degradation of cichoric acid in Echinacea purpurea preparations, J. Nat. Prod., 63: 1615-1618.
Osowski, S., Rostock, M., Bartsch, H.-H., et al., 2000, Pharmaceutical comparability of different therapeutic Echinacea preparations, Forsch Komplementärmed Klass Naturheilkd, 7: 294-300.
Parnham, M.J., 1996, Benefit-risk assessment of the squeezed sap of the purple coneflower (Echinacea purpurea) for long-term oral immunostimulation, Phytomedicine, 3: 95-102.
Stoll, A., Renz, J. and Brack, A., 1950, Isolation and constitution of echinacoside, a glycoside from the roots of Echinacea angustifolia D.C., Helv. Chim. Acta, 33: 1877-1893.
Wagner, H. and Proksch, A., 1981, An immunostimulating active constituent from Echinacea purpurea, Z. Phytother., 2: 166-171.
Wagner, H., 1996, Herbal immunostimulants, Z. Phytother., 17: 79-95.
Wills, R.B.H. and Stuart, D.L., 1998, Levels of active constituents in manufactured Echinacea products, Chem. Aust., 9: 17-19.
Was this article helpful?
All Natural Immune Boosters Proven To Fight Infection, Disease And More. Discover A Natural, Safe Effective Way To Boost Your Immune System Using Ingredients From Your Kitchen Cupboard. The only common sense, no holds barred guide to hit the market today no gimmicks, no pills, just old fashioned common sense remedies to cure colds, influenza, viral infections and more.